| Literature DB >> 35899082 |
Xiangyong Tian1, Nan Jing2, Wenjing Duan3, Xiaoqiang Wu1, Chan Zhang1, Shanmei Wang2, Tianzhong Yan1.
Abstract
Background: Ralstonia mannitolilytica, an emerging opportunistic pathogen, can infect immunocompromised patients but is a rare cause of severe sepsis and septic shock in kidney transplant recipients (KTRs). Case Presentation: We present a case of septic shock after renal transplant in a 41-year-old male, which was finally proven to be caused by Ralstonia mannitolilytica through blood cultures and mass spectrometric analysis following the negative result of metagenomic next-generation sequencing (mNGS). He was finally cured after the application of sensitive antibiotics (sulfamethoxazole-trimethoprim, amikacin and piperacillin-tazobactam) based on the drug sensitivity test results. The patient had a satisfactory recovery with no complications during a 6-month follow-up period.Entities:
Keywords: Ralstonia mannitolilytica; blood cultures; kidney transplant; mNGS; metagenomic next-generation sequencing; sepsis
Year: 2022 PMID: 35899082 PMCID: PMC9309314 DOI: 10.2147/IDR.S370170
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.177
Laboratory Findings
| Laboratory Test | Second Postoperative Day | Shock Time | Third Postoperative Day | Eighth Postoperative Day | 17th Postoperative Day | 27th Postoperative Day | Reference Range |
|---|---|---|---|---|---|---|---|
| Leukocyte (109/L) | 14.78 | 2.55 | 12.94 | 7.42 | 2.14 | 4.82 | 3.5–9.5 |
| Neutrophils (109/L) | 14.12 | 2.51 | 12.48 | 6.73 | 1.34 | 3.48 | 1.8–6.3 |
| Lymphocytes (109/L) | 0.11 | 0.03 | 0.16 | 0.25 | 0.40 | 0.71 | 1.1–3.2 |
| Platelets (109/L) | 131 | 62 | 51 | 29 | 92 | 184 | 125–350 |
| CRP (mg/L) | 25.69 | 13.52 | 52.68 | 8.81 | 6.00 | <0.50 | 0–10 |
| PCT (ng/mL) | 0.30 | >200 | >200 | 8.39 | 0.27 | N | 0–0.05 |
| D-dimer (μg/mL) | 6.73 | 57.35 | 23.04 | 6.70 | N | 2.34 | 0–0.55 |
| FDP (μg/mL) | 25.08 | 226.44 | 108.09 | 21.85 | N | 6.90 | 0–5 |
| Creatinine (μmoI/L) | 141 | 151 | 163 | 204 | 136 | 112 | 58–115 |
| Urea (mmol/L) | 10.2 | 14.0 | 15.8 | 31.5 | 9.1 | 13.1 | 3.2–7.1 |
| BNP (pg/mL) | 2620 | 2680 | 11,400 | 5160 | 4730 | N | 0–125 |
Abbreviations: CRP, C-reactive protein; PCT, procalcitonin; FDP, fibrin degradation product; BNP, brain natriuretic peptide; N, none.
Figure 1Colony characteristics and gram staining of R. mannitolilytica. (A) R. mannitolilytica grew on Columbia blood agar for 24 hours. Colonies are round, small, 1–2mm, grey, moist. (B) Gram staining suggested gram-negative bacilli in the blood culture bottle (10×100). R. mannitolilytica is indicated by arrows.
Susceptibility of Antibiotics to the Ralstonia mannitolilytica Isolate
| Antibiotic | R/S | MIC ug/mL | Antibiotic | R/S | MIC ug/mL |
|---|---|---|---|---|---|
| Ampicillin | R | >16 | Gentamicin | S | ≤2 |
| Amikacin | S | ≤8 | Imipenem | R | >8 |
| Aztreonam | R | >16 | Levofloxacin | R | >8 |
| Chloramphenicol | R | >16 | Meropenem | R | >8 |
| Ceftazidime | S | ≤1 | Moxifloxacin | R | >4 |
| Ciprofloxacin | R | >2 | Ampicillin Sulbactam | R | >16/8 |
| Cefotaxime | S | 8 | sulfamethoxazole- trimethoprim | S | ≤0.5/9.5 |
| Cefazolin | R | >16 | Piperacillin-tazobactam | S | ≤4/4 |
| Cefepime | S | ≤2 |
Abbreviations: R, resistant; S, susceptible; MIC, minimum inhibitory concentration.